---
figid: PMC6186311__OMCL2018-7019573.005
figlink: /pmc/articles/PMC6186311/figure/fig5/
number: F5
caption: 'Beneficial effect of RC on hepatic glucose and lipid metabolism signalling
  pathways. RC prevents hepatic damages associated to NAFLD through different mechanisms:
  (a) promotes oxidative balance: ROS, prooxidant p22phox, Erk1/2, and Nrf2 degradation
  inhibitions; (b) improves insulin sensitivity: inhibits IRS1Ser-phosphorylation;
  (c) normalises SIRT1 levels and promotes its beneficial effects; (d) NF-κB and inflammatory
  pathway attenuation; (e) increases β-fatty acid oxidation and gluconeogenesis: PPARα
  stimulation, PPARγ, and adipogenesis inhibitions; (f) reduces de novo lipogenesis:
  maintains SREPB1c, ChREBP, and SREPB2 physiological levels, decreases hepatic triglycerides
  and cholesterol; (g) increases glycogenogenesis rate: GS expression normalisation;
  (h) ameliorates plasma adipokine and lipid contents. u: ubiquitin; ---: interpathway
  interactions; →: stimulatory activity; ┤: inhibitory activity; X: suppression.'
pmcid: PMC6186311
papertitle: 'Treatment of NASH with Antioxidant Therapy: Beneficial Effect of Red
  Cabbage on Type 2 Diabetic Rats.'
reftext: Stéphanie Dal, et al. Oxid Med Cell Longev. 2018;2018:7019573.
pmc_ranked_result_index: '114125'
pathway_score: 0.877268
filename: OMCL2018-7019573.005.jpg
figtitle: Beneficial effect of RC on hepatic glucose and lipid metabolism signalling
  pathways
year: '2018'
organisms:
- Homo sapiens
ndex: 25c1b81b-df0e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6186311__OMCL2018-7019573.005.html
  '@type': Dataset
  description: 'Beneficial effect of RC on hepatic glucose and lipid metabolism signalling
    pathways. RC prevents hepatic damages associated to NAFLD through different mechanisms:
    (a) promotes oxidative balance: ROS, prooxidant p22phox, Erk1/2, and Nrf2 degradation
    inhibitions; (b) improves insulin sensitivity: inhibits IRS1Ser-phosphorylation;
    (c) normalises SIRT1 levels and promotes its beneficial effects; (d) NF-κB and
    inflammatory pathway attenuation; (e) increases β-fatty acid oxidation and gluconeogenesis:
    PPARα stimulation, PPARγ, and adipogenesis inhibitions; (f) reduces de novo lipogenesis:
    maintains SREPB1c, ChREBP, and SREPB2 physiological levels, decreases hepatic
    triglycerides and cholesterol; (g) increases glycogenogenesis rate: GS expression
    normalisation; (h) ameliorates plasma adipokine and lipid contents. u: ubiquitin;
    ---: interpathway interactions; →: stimulatory activity; ┤: inhibitory activity;
    X: suppression.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADIPOQ
  - PRKAG2
  - PRKAG3
  - MAPK1
  - GNAL
  - SOD3
  - SREBF1
  - SREBF2
  - GNAS
  - SOD2
  - TG
  - IRS1
  - PRKAA1
  - IRS4
  - CAT
  - MLXIPL
  - MAPK3
  - PRKAB2
  - PRKAA2
  - PRKAB1
  - CYBA
  - PRKAG1
  - IRS2
  - PPARA
  - SOD1
genes:
- word: Adiponectin
  symbol: adiponectin
  source: hgnc_alias_symbol
  hgnc_symbol: ADIPOQ
  entrez: '9370'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GS
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: SOD
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD3
  entrez: '6649'
- word: SREBP1C
  symbol: SREBP-1c
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: SREBP2
  symbol: SREBP2
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF2
  entrez: '6721'
- word: GS
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: SOD
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD2
  entrez: '6648'
- word: TG
  symbol: TG
  source: hgnc_symbol
  hgnc_symbol: TG
  entrez: '7038'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: CAT)
  symbol: CAT
  source: hgnc_symbol
  hgnc_symbol: CAT
  entrez: '847'
- word: CHREBP
  symbol: CHREBP
  source: hgnc_alias_symbol
  hgnc_symbol: MLXIPL
  entrez: '51085'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: IRS1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: p22phox
  symbol: p22-PHOX
  source: hgnc_alias_symbol
  hgnc_symbol: CYBA
  entrez: '1535'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: PPARA
  symbol: PPARA
  source: hgnc_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: SOD
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD1
  entrez: '6647'
chemicals: []
diseases: []
figid_alias: PMC6186311__F5
redirect_from: /figures/PMC6186311__F5
figtype: Figure
---
